Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial
DiscussionIf the preliminary findings of EXERT are positive, additional research will be warranted to confirm whether exercise is an innovative treatment to maintain QoL, manage side effects, and/or improve treatment outcomes in rectal cancer patients.Trial registrationClinicalTrials.gov, ID:NCT03082495. Registered on 9 February, 2017.
Source: Trials - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cardiology | Heart | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Rectal Cancers | Research | Sports Medicine | Study | Toxicology | Training | Universities & Medical Training